Your browser doesn't support javascript.
loading
Discrepant Bowel Perforation from a Primary Lesion after Chemotherapy of Diffuse Large B Cell Lymphoma
Journal of the Korean Surgical Society ; : 61-65, 2009.
Article in English | WPRIM | ID: wpr-170258
ABSTRACT
Diffuse large B cell lymphoma is the most common type of non-Hodgkin's lymphoma, representing approximately one-third of all cases and involving the gastrointestinal tract in about 18%. With the development of modern chemotherapeutic regimens and advances in medical care, the prognosis for malignant lymphoma can be excellent. However, because of the aggressive adjuvant therapy required, complications such as bowel perforation may be fatal. In cases of chemotherapy for malignant lymphoma, we should keep in mind the possibility of perforation of the bowel after chemotherapy. Early detection is important to save patients.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prognosis / Lymphoma, Non-Hodgkin / Lymphoma, B-Cell / Gastrointestinal Tract / Lymphoma Type of study: Prognostic study / Screening study Limits: Humans Language: English Journal: Journal of the Korean Surgical Society Year: 2009 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prognosis / Lymphoma, Non-Hodgkin / Lymphoma, B-Cell / Gastrointestinal Tract / Lymphoma Type of study: Prognostic study / Screening study Limits: Humans Language: English Journal: Journal of the Korean Surgical Society Year: 2009 Type: Article